Not on air · 2 of 3 networks checked
Batavia Biosciences
- bataviabiosciences.com
- Healthcare & Life Sciences
- NL
- 56 employees
Batavia Biosciences’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 183. Watch Batavia Biosciences with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| None recorded | 0 | Checked 30 Oct 2026 | See all 183 ads → | ||
| Meta | Not checked | — | |||
| Recently | 9 | Ads on the Google Ads Transparency Center | Checked 9 Oct 2026 | Collect them with the API → |
Batavia Biosciences has no live LinkedIn ads. We recorded 9 Google ads on 9 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 16 Oct 2025
What if cancer-killing viruses could selectively replicate in tumors while leaving healthy tissue untouched? In Batavia Biosciences’ latest blog, SATOR Therapeutics’ Dr. Anton A. Komar reveals how their patented synonymous codon optimization fine-tunes viral genomes to mirror cancer cell translation patterns. The result: oncolytic viruses proliferate faster in cancer cells but remain attenuated in normal tissue—a leap forward in safety and selectivity. Read it here: https://lnkd.in/d2DyPYVy #OncolyticViruses #CancerTherapy #ImmunoOncology #BiotechInnovation #BataviaBiosciences
- LINKEDIN · IMAGESince 16 Oct 2025
Imagine if cancer-killing viruses could distinguish tumor cells from healthy cells. In this latest blog by Batavia Biosciences, SATOR Therapeutics’ Dr. Anton A. Komar shares how their patented synonymous codon optimization reprograms viral genomes to align with cancer cell translation patterns, enabling selective replication in tumors while sparing normal tissue. The result? A smarter, safer oncolytic virotherapy designed for targeted cancer treatments. Read it here: https://lnkd.in/d2DyPYVy #OncolyticViruses #CancerTherapy #ImmunoOncology #BiotechInnovation #BataviaBiosciences
- LINKEDIN · IMAGESince 11 Oct 2025
Biotech innovators like SATOR Therapeutics are reshaping what we prioritize in cancer treatment with oncolytic virus (OV) therapy. At the heart of this shift is one key principle: precision targeting. In our latest blog, we spoke with Dr. Anton A. Komar of SATOR Therapeutics about the unique promise of OVs, the challenges researchers face in OV development, and the distinctions between natural and bioengineered OVs. Read today to learn why these therapies are poised to shape the future of oncology.
- LINKEDIN · IMAGESince 11 Oct 2025
Pioneering biotechs such as SATOR Therapeutics are actively shaping the future of cancer treatments with oncolytic virus (OV) therapy. Central to this innovation is precision targeting; In our newest blog, we sat down with Dr. Anton A. Komar of SATOR Therapeutics to explore the promise of OVs, common hurdles in their development, and the key differences between natural and engineered OV strains. Read today to learn why the future of targeted cancer therapies lies in oncolytic viruses.
- LINKEDIN · IMAGESince 2 Oct 2025
At BIO-Europe 2025, partnerships are “the science of connection,” which is why Batavia Biosciences is excited to announce our attendance. Join us from November 3-5 in Vienna, Austria where we’ll be shaking hands with some of the most productive and innovative biotech professionals in the industry. Be sure to drop by Booth #C137 to hear all about our process development and commercial manufacturing services for viral vectors, viral vaccines, and oncolytic viruses.
- LINKEDIN · IMAGESince 2 Oct 2025
At BIO-Europe 2025, it’s all about building meaningful connections—and Batavia Biosciences is proud to connect with the most innovative biotech professionals around the globe. From November 3–5 in Vienna, our team will be at Booth #C137, ready to share how our process development and commercial manufacturing services accelerate the development viral vectors, viral vaccines, and oncolytic viruses.
6 of 183 adsSign up to see every Batavia Biosciences ad, filter by format and date, and get alerts on new ones.
See all 183 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.